Dr Henry Cutler is the inaugural director of the Centre for the Health Economy at Macquarie University, where he investigates the Health Economy at the macro level, with particular focus on the interdependencies of these systems with each other, and the broader economy.

Henry has led or co-authored over 90 health economics research publications on a broad range of topics for federal and state government departments, government agencies, and Australian and international non-government organisations.

His research focuses on economic evaluation, policy analysis, and forecasting in health and human services using a variety of economic tools and modelling techniques. He has undertaken major studies on health and aged care reform, private health insurance, hospital efficiency, pharmaceuticals, medical devices, blood products, integrated care, hearing services, health care workforce, and mental health care. He regularly comments in the media on health care related topics, including for the ABC, Australian Financial Review, The Australian, and other media outlets.

Henry is also an investigator within the NHMRC Centre for Research Excellence in Digital Health, NHMRC Centre for Suicide Prevention, Macquarie University’s Centre for Emotional Health and Macquarie University’s Centre for Reading.

He has a PhD from UNSW, where his research focused on measuring patient preferences for healthcare system performance, and increasing allocative efficiency within the health care system. Prior to Macquarie University, Henry was the national lead of KPMG’s health economics group, and led the Sydney health and social policy team at Access Economics. He was also a senior economist at the Centre for International Economics.

Matthew joined NHS England in May 2016 from the Cerner Group, where he was Senior Vice President for Population Health and Global Strategy. He is responsible for national performance of the NHS against the NHS Constitution Standards, assurance of Clinical Commissioning Groups, achieving digital transformation, and information and technology programmes.

He has over 25 years’ experience in health care services, and has worked in the Department of Health and the Prime Minister’s Office of Public Service Reform.

Matthew began his career at Guys and St Thomas’ Hospital in the early 1990s, and went on to become Director of Clinical Services of Heatherwood and Wexham Park Hospital and later Chief Executive of the Royal Surrey County Hospital.

He is visiting professor and chair of the advisory committee in the School of Health Management at the University of Surrey and Member of the Editorial Board for the Journal of Population Health Management.

Kirsten O’Doherty is the ANZ General Manager of biopharmaceutical company, AbbVie where she leads a team of 300+ staff across Australia and New Zealand. She is a member of the AbbVie regional leadership team in Asia, including Japan. AbbVie is focused on discovering, developing, and delivering medicines in therapeutic areas where the company has proven expertise and where the most impact can be made. These areas include immunology, oncology, virology and neuroscience. AbbVie has been ranked in the top three companies for the PatientView reputation survey since 2016 and has been named one of Australia’s ‘Best Places to Work’ in the Great Place to Work index for several consecutive years, including a category ranking of #7 in 2018. Originally qualified and working as a hospital pharmacist, Kirsten’s career has subsequently spanned more than 20 years in the Australian pharmaceutical industry, moving from initial clinical research and medical roles to commercial roles, and finally into senior leadership roles. Throughout her career, Kirsten has remained committed to continuing professional development. She is a Graduate of the Australian Institute of Company Directors, and has undertaken residential senior leadership programs at the London Business School, and at IMD in Switzerland. Kirsten has a breadth and depth of experience including leadership of financial performance, marketing and sales excellence, strategic planning, change management and creating high levels of employee engagement. Kirsten is on the Board of Medicines Australia, the industry association for the pharmaceutical industry. In this capacity, she is also the Chair of the Nominations Committee and is the Co-Founder of the Pharma Australia Gender Equity (PAGE) Group. In recognition of her commitment to advancing workplace gender equality, Kirsten is listed as a Pay Equity Ambassador with the Workplace Gender Equality Agency.

Dr Rob Grenfell, a Public Health Physician, is the Director of CSIRO’s Health and Biosecurity Business Unit. Leading a broad portfolio covering Nutrition, eHealth, Medtech and Diagnostics and Biosecurity from weeds to Ebola. Rob has broad ranging public health experience including; National Medical Director at BUPA Australia New Zealand National Director Cardiovascular Health at the Heart Foundation Strategic Health Advisor to Parks Victoria Senior Medical Advisor at the Department of Health Victoria Physician in charge of travel health BHP General Practice He was a member of the Safety and Quality Outcomes Committee of the Hospital Innovation Reform Council, a member of the Victorian Quality Council, Chair of General Practice Victoria, and Member of the Health Advisory Committee of the National Health and Medical Research Council.

Dr Lachlan Henderson is a medical practitioner who has 30 years’ experience in the health industry. Prior to taking on a variety of executive leadership roles, he was a General Practitioner for over a decade. Lachlan is currently Group Chief Executive of Epworth HealthCare, a role he took on in January 2017. Epworth is the largest private, not for profit hospital group in Victoria with revenue in excess of $900m, employing over 7000 staff across nine sites. In his career, Lachlan has held a variety of University and Board appointments. He is currently Vice President of the Australian Private Hospitals Association (APHA) and a Board Member of Cricket Australia.

Dr Michael Brydon was permanently appointed to the role of Chief Executive of the Sydney Children’s Hospitals Network in July 2016. Prior to the network forming, Michael worked at Sydney Children’s Hospital, Randwick for 27 years after completing his undergraduate Medical Degree at UNSW and his Fellowship of Paediatrics in the Randwick program. His other post-graduate qualifications include a Masters of Paediatrics and a Masters of Health Administration from UNSW. In the last two decades, Michael has held an increasingly more senior management portfolio across a local, state and national agenda. As a result of these roles, he has established a wide network of professional partnerships, predominantly in the child health environment and gained significant expertise in clinical management and medical administration. Ever since entering paediatrics, Michael has advocated for children and their families, highlighting the differences in their needs and ensuring a fair allocation of resources to paediatrics.

Dr Diane Watson is the Chief Executive of the Bureau of Health Information. She has led the establishment of three reporting agencies in Australia that use big data to drive decisions on healthcare provision nationally and locally.

Prior to joining BHI, Dr Watson was the inaugural Chief Executive Officer of the Victorian Agency for Health Information, established in 2016 to monitor and report on public and private services that stimulate quality and safety improvements, increase transparency and accountability, and inform the community. She was also the inaugural Chief Executive of the National Health Performance Authority, established by the Australian Government to monitor, and report on, the performance of 1000+ public and private hospitals and 300+ health regions.

Dr Watson was the inaugural Chief Executive of the Bureau of Health Information from 2009 to 2012. She has held senior management positions for almost 20 years measuring, monitoring and reporting on the performance of healthcare systems to drive improvements in health, care and productivity. During this time, she has set the future direction of high profile, board governed agencies and inspired a strong sense of purpose among a highly talented and specialised workforce.

Dr Shane Kelly was appointed Group Chief Executive Officer of St John of God Health Care in June 2018. Dr Kelly completed his medical degree at the University of Western Australia, following which he worked at Sir Charles Gairdner Hospital in clinical roles. He went on to complete a Masters of Business Administration and a Masters of Public Health and took on senior management roles in Western Australia including as the Chief Executive of the Women’s and Children’s Health Service and subsequently the South Metropolitan Health Service. Before joining St John of God Health Care, Dr Kelly was Group Chief Executive Officer of Mater Misericordiae in Queensland and prior to that he was Chief Executive of the North Metropolitan Health Service. He also spent more than eight years as the Chief Executive Officer of St John of God Subiaco Hospital. Dr Kelly is a Fellow of the Royal Australasian College of Medical Administrators, the Australasian College of Health Service Management, the Australian Institute of Company Directors and the Institute of Managers and Leaders (formerly Australian Institute of Management). He is an Adjunct Professor at the University of Queensland (Faculty of Medicine and Faculty of Health and Behavioural Sciences) and an Adjunct Professor of Australian Catholic University. His main professional interests are in relation to health system performance and accountability, and the provision of safe, high quality evidence-based patient care.

The minute you meet Mark you know he is passionate about access to world-class healthcare. As the Group CEO, and a highly-regarded radiation therapist, Mark knows all too well the impact of cancer on patients, family and society. His leadership style is simple, nurture and challenge a team to deliver exceptional cancer care and grow the business to deliver that care for as many people as possible.

Since taking the reins in 2015, Mark has delivered a robust growth profile. In this time the Group has expanded into Singapore, New Zealand and China, with a significant South-East Asia reach, delivered a 50% increase in their radiation oncology footprint and driven acquisition in the chemotherapy compounding space to deliver one of Australia’s largest oncology manufacturers. Having worked in cancer care in both North America and Europe Mark led and founded Radiation Oncology Centres (ROC) which became part of Icon in 2014. He has published 25 peer reviewed scientific papers and is a frequently invited key note speaker both nationally and internationally. In 2018 he was announced as a Director on the inaugural Union of International Cancer Control’s (UICC) City Cancer Challenge Board.

Mark was a State Finalist for the Australian Institute of Management [AIM] Queensland Manager of the Year in 2014 and regional winner of the AIM Excellence Award 2015. He has a Master of Business Administration from Deakin University and is a Fellow of both the AIM and the Australian Institute of Radiography [AIR].

Annie Butler is the Federal Secretary for the Australian Nursing and Midwifery Federation. Annie was formally appointed to the role in June 2018, having served as the Assistant Federal Secretary since March 2014, and following years of experience in the clinical, professional and industrial areas of nursing. Annie is a registered nurse with more than a decade’s experience working in public hospitals, the community and on health education projects, and a further decade working in research and education. She worked for the New South Wales Nurses and Midwives’ Association, for a further decade, as a professional officer, organiser and lead organiser, prior to moving to the national position of Assistant Federal Secretary and now holding the position of Federal Secretary Annie believes that we must fight to maintain the professions of nursing and midwifery in Australia and ensure their advancement. She is passionate about improving Australia’s system of health and aged care and the critical role nurses and midwives have to play in the future of our health system. Annie is particularly keen to see nurses drive change for improvements in Australia’s aged care sector. Annie has a degree in Health Science, an Honour’s degree in Nursing and is currently completing a Bachelor of Economics.

Angela is the Australian Digital Health Agency’s Acting Chief Clinical Information Officer. Angela is a Clinical Leadership and Health Informatics Professional with 30 years’ experience in Hospitals and Public Sector Organisations, with more than two decade’s experience as a paediatric and adult intensive care Nurse. Angela is a Fellow of the Australasian College of Health Informatics and serves as President of the ACHI Council. In 2017 Angela was awarded a Churchill Fellowship to study methods to prevent patient harm through national digital health safety governance and has recently completed travel to the UK, USA and Canada as part of the Churchill Fellowship research. The report will be published later this year.

Dr Teresa Anderson, Chief Executive of the Sydney Local Health District with over 30 years’ experience as a clinician and manager in the public health system. Her roles included General Manager, Liverpool Hospital and Director, Clinical Operations, Former Sydney South West Area Health Service. A graduate of this University with a Bachelor of Applied Science (Speech Pathology), Teresa then went on to complete a PhD in Linguistics at Macquarie University on the Early Identification and Treatment of Communication Disorders in Infancy. Dr Anderson is also currently Chair of the Sydney Research Council, a partnership between the University of Sydney, Sydney Local Health District and the Medical Research Institutes.

Frank Tracey is the Executive Director Clinical Services at Children’s Health Queensland Hospital and Health Service (CHQ HHS). He holds a clinical operational portfolio and leads the Planning Improvement and Innovation functions for the organisation. Frank has more than 30 years’ experience working in health systems. This experience includes executive roles in large health organisations. Frank has a clinical background in nursing and holds advanced qualifications in health management and governance. His extensive experience in health commissioning and provision in clinical and community settings is complemented by strong managerial and leadership skills, and an applied interest in population health planning and translational health research. While working in both government and non-government roles Frank has focused on delivering sustainable health strategies that serve the best interests of patients, health professionals, the broader health system and the community.

Bruce Goodwin’s career with the Johnson & Johnson family of companies spans thirty five years.

He has been in General Management roles for the last ten years including two terms in his current role of Managing Director Janssen Australia and New Zealand, and also three years as President and Representative Director Janssen Japan.

Prior to General Management he has held Management Board Director positions in Sales and Marketing and in Finance, as well as having gained valuable experience in Global Licensing and Acquisitions. His service with Johnson & Johnson outside of his home country, Australia, includes postings to Janssen Japan, Janssen Belgium and Janssen United Kingdom.

Bruce is a respected Industry Leader and is currently an elected Director and Board Member of Medicines Australia, a role he has also held previously. Whilst in Japan he served as the Vice Chair of the Japan Based Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Bruce has a strong track record in advocating for policies that support timely and affordable access to innovative medicines and has recently been appointed as a Director and Board member of the Australian Genomic Cancer Medicine Program. In 2017 he was also a key member of the Cancer Drugs Access Committee.

Bruce holds an Economics degree from Macquarie University, an MBA from Macquarie Graduate School of Management, and is a Graduate Member of the Australian Institute of Company Directors (GAICD).

Ian McCrae founded Orion Health in 1993, an award-winning, global provider of healthcare information technology advancing population health and precision medicine solutions. Passionate about the role that technology plays in making personalised healthcare a reality, Ian led the development of the company’s flagship products – Rhapsody Integration Engine and Amadeus. Amadeus, Orion’s big data cloud-based platform, helps manage more than a 100 million patients records globally. Ian holds a Masters in Engineering Science and a Bachelor of Engineering from the University of Auckland, New Zealand.

A/ Prof Clair Sullivan is currently the Chief Digital Health Officer at Metro North Hospital and Health Service. A/ Prof Sullivan graduated with Honours in Medicine and a Research Doctorate in Medicine (UK). She is a fellow of both the Royal Australasian College of Physicians and the Australian College of Health Informatics. She has been appointed Associate Professor of Clinical Informatics at the University of Queensland and is widely published in clinical informatics and serves on several national advisory boards for digital health.